FDA approved Papzimeos (zopapogene imadenovec), the first-in-class, non-replicating adenoviral vector-based immunotherapy, ...

Health and Human Services Secretary Robert F. Kennedy Jr. publicly denied speculation that he is preparing a 2028 ...